| Date |
Time |
Source |
Heading |
|---|
| 12/21/2023 | 15:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
| 12/05/2023 | 18:26 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/01/2023 | 11:49 | EDGAR2 | Form 8-K - Current report |
| 11/16/2023 | 16:55 | EDGAR2 | Form 8-K - Current report |
| 10/23/2023 | 13:56 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
| 10/05/2023 | 21:01 | BW | Navidea Biopharmaceuticals, Inc. Announces NYSE American’s.. |
| 10/05/2023 | 16:21 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 9/15/2023 | 15:42 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 9/11/2023 | 00:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 8/15/2023 | 17:53 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 8/11/2023 | 16:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/10/2023 | 09:29 | BW | Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing.. |
| 8/08/2023 | 16:23 | EDGAR2 | Form 8-K - Current report |
| 7/31/2023 | 09:32 | BW | Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces.. |
| 7/28/2023 | 20:23 | BW | Navidea Biopharmaceuticals, Inc. Announces NYSE American Has.. |
| 7/28/2023 | 17:10 | EDGAR2 | Form 8-K - Current report |
| 7/27/2023 | 17:20 | BW | Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as.. |
| 7/17/2023 | 18:02 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 7/17/2023 | 18:00 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 7/13/2023 | 17:27 | EDGAR2 | Form 8-K - Current report |
| 7/13/2023 | 17:09 | BW | Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to.. |
| 7/06/2023 | 16:39 | EDGAR2 | Form 8-K - Current report |
| 7/03/2023 | 17:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 7/03/2023 | 16:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 6/30/2023 | 16:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 6/30/2023 | 10:46 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 6/30/2023 | 09:16 | BW | Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer.. |
| 6/16/2023 | 16:54 | BW | Navidea Biopharmaceuticals, Inc. Announces Distribution of.. |
| 6/16/2023 | 13:52 | BW | Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash.. |
| 6/07/2023 | 16:00 | BW | Navidea Biopharmaceuticals, Inc. Reports First Quarter 2023.. |
| 6/02/2023 | 17:54 | BW | Navidea Biopharmaceuticals, Inc. Receives NYSE American.. |
| 6/01/2023 | 17:53 | BW | Navidea Biopharmaceuticals, Inc. Welcomes Jill Bieker.. |
| 5/22/2023 | 18:30 | BW | Navidea Biopharmaceuticals, Inc. Investors Purchase $1.1.. |
| 5/11/2023 | 17:35 | BW | Navidea Biopharmaceuticals, Inc. Promotes Michael Sherman.. |
| 5/08/2023 | 16:12 | BW | Navidea Biopharmaceuticals, Inc. Drives Strategy Forward,.. |
| 4/27/2023 | 17:14 | BW | Navidea Biopharmaceuticals, Inc. Announces Intent to sell.. |
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
